On January 10, 2020 Rakuten Medical, Inc. (RMI) a clinical-stage, global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer treatment platform, Illuminox, reported that will present at the 38th Annual J.P. Morgan Healthcare Conference being held January 13-16, 2020, in San Francisco (Press release, Rakuten Medical, JAN 10, 2020, View Source [SID1234552977]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Rakuten Medical’s Chairman and CEO, Hiroshi "Mickey" Mikitani, will present at 4:30 p.m. PST, Monday, Jan. 13 at the Westin St. Francis Hotel, Elizabethan Room C/D.

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.